It also addresses the FDA’s communications with the applicant, the retention of documents that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report to a brand new applicant and Digital submission in the SE report and amendments.Cl